serena williams glp-1 ro is in a new ad campaign for weight loss medication (GLP-1 from Ro), but this is a complex story with two very different sides. Is this a brave move to normalize the medication or a SERENA WILLIAMS JOINS RO AS

The culmination of these scientific advancements provides valuable insights for the development of more effective treatments for metabolic disorders, ultimately paving the way for improved patient outcomes in the realm of metabolic health

The FDA has approved GLP-1 receptor agonists for specific medical uses, such as managing type 2 diabetes and chronic weight management

You therefore do not digest them in the same way that you do whole foods, which could affect your gut health

Experts remain cautiously optimistic about Berberines therapeutic potential, especially in managing type 2 diabetes and metabolic disorders

(link to article in the comments) #GLP1s #WeightLossDrugs #EmployeeBenefits To view or add a comment, sign in 27% of employers say GLP-1 weight-loss drugs made up more than 15% of their total annual claims in 2024

In any case, most side effects were tolerable and tended to get better with time